Skip to main content Accessibility help
×
Home

Comparison of the Duration of Antimicrobial Activity of 2 Different Antimicrobial Central Venous Catheters

  • Theofilos Matheos (a1), J. Matthias Walz (a1) (a2), Janice P. Adams (a1), Karen Johnson (a1), Karen Longtine (a1), Jaclyn Longtine (a1), Melissa O'Neill (a1) and Stephen O. Heard (a1) (a2)...

Extract

We compared the duration of antimicrobial effectiveness of 2 different antimicrobial catheters. The baseline activity of minocycline-rifampin catheters was greater than that of silver-platinum-carbon catheters against Staphylococcus aureus, Staphylococcus epidermidis, and Enterococcus faecalis. The antimicrobial activity of the minocycline-rifampin catheters against these pathogens persisted for up to 12 days, while that of the silver-platinum-carbon catheters was depleted by day 10 (P< .05).

Copyright

Corresponding author

Department of Anesthesiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655 (stephen.heard@umassmed.edu)

References

Hide All
1.Mermel, LA. Prevention of intravascular catheter–related infections (published correction appears in Ann Intern Med 2000;133:395). Ann Intern Med 2000;132:391402.
2.Darouiche, RO, Raad, II, Heard, SO, et al.A comparison of two anti-microbial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999;340:18.
3.Maki, DG, Stolz, SM, Wheeler, S, Mermel, LA. Prevention of central venous catheter–related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127:257266.
4.Fraenkel, D, Rickard, C, Thomas, P, Faoagali, J, George, N, Ware, R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006;34:668675.
5.Marik, PE, Abraham, G, Careau, P, Varon, J, Fromm, RE JrThe ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999;27:11281131.
6.Bassetti, S, Hu, J, D'Agostino, RB JrSherertz, RJ. In vitro zones of inhibition of coated vascular catheters predict efficacy in preventing catheter infection with Staphylococcus aureus in vivo. Eur J Clin Microbiol Infect Dis 2000;19:612617.
7.Raad, I, Darouiche, R, Hachem, R, Mansouri, M, Bodey, GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996;173:418424.
8.Hanna, H, Bahna, P, Reitzel, R, et al.Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother 2006;50:32833288.
9.Yorganci, K, Krepel, C, Weigelt, JA, Edmiston, CE. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. Eur J Clin Microbiol Infect Dis 2002;21:379384.
10.Quinn, MT, Milder, FL. The Science of Oligon. http://ht.edwards.com/resourcegallery/products/centralvenousaccess/pdfs/scienceofoligon1124.pdf. Irvine, CA: Edwards Lifesciences; 2002. Accessed August 25, 2009.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed